Davenport & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.46M Sell
13,608
-49
-0.4% -$5.26K 0.01% 576
2025
Q1
$1.38M Buy
13,657
+1,828
+15% +$184K 0.01% 557
2024
Q4
$1.06M Buy
11,829
+561
+5% +$50.1K 0.01% 613
2024
Q3
$944K Sell
11,268
-6
-0.1% -$503 0.01% 636
2024
Q2
$868K Buy
11,274
+2,467
+28% +$190K 0.01% 632
2024
Q1
$603K Buy
8,807
+34
+0.4% +$2.33K ﹤0.01% 732
2023
Q4
$507K Buy
8,773
+22
+0.3% +$1.27K ﹤0.01% 745
2023
Q3
$462K Hold
8,751
﹤0.01% 736
2023
Q2
$473K Sell
8,751
-671
-7% -$36.3K ﹤0.01% 740
2023
Q1
$471K Sell
9,422
-728
-7% -$36.4K ﹤0.01% 722
2022
Q4
$470K Sell
10,150
-15,076
-60% -$698K ﹤0.01% 701
2022
Q3
$977K Buy
25,226
+14,641
+138% +$567K 0.01% 485
2022
Q2
$395K Sell
10,585
-288
-3% -$10.7K ﹤0.01% 723
2022
Q1
$482K Sell
10,873
-728
-6% -$32.3K ﹤0.01% 731
2021
Q4
$493K Sell
11,601
-933
-7% -$39.6K ﹤0.01% 738
2021
Q3
$544K Sell
12,534
-2,178
-15% -$94.5K ﹤0.01% 698
2021
Q2
$629K Buy
14,712
+3,708
+34% +$159K ﹤0.01% 589
2021
Q1
$425K Sell
11,004
-3,940
-26% -$152K ﹤0.01% 567
2020
Q4
$537K Buy
14,944
+256
+2% +$9.2K 0.01% 504
2020
Q3
$561K Sell
14,688
-595
-4% -$22.7K 0.01% 438
2020
Q2
$537K Sell
15,283
-1,094
-7% -$38.4K 0.01% 448
2020
Q1
$534K Buy
16,377
+110
+0.7% +$3.59K 0.01% 389
2019
Q4
$736K Buy
16,267
+949
+6% +$42.9K 0.01% 396
2019
Q3
$658K Hold
15,318
0.01% 398
2019
Q2
$658K Sell
15,318
-605
-4% -$26K 0.01% 397
2019
Q1
$611K Buy
15,923
+5,135
+48% +$197K 0.01% 384
2018
Q4
$381K Buy
10,788
+2,248
+26% +$79.4K 0.01% 456
2018
Q3
$329K Buy
8,540
+2,192
+35% +$84.4K ﹤0.01% 529
2018
Q2
$208K Buy
+6,348
New +$208K ﹤0.01% 644